1222 related articles for article (PubMed ID: 25400449)
1. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
Chen WX; Ren LH; Shi RH
World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
[TBL] [Abstract][Full Text] [Related]
4. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
[TBL] [Abstract][Full Text] [Related]
5. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Berg D; Clemente JC; Colombel JF
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
[TBL] [Abstract][Full Text] [Related]
6. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbiota and ulcerative colitis.
Ohkusa T; Koido S
J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
Orel R; Kamhi Trop T
World J Gastroenterol; 2014 Sep; 20(33):11505-24. PubMed ID: 25206258
[TBL] [Abstract][Full Text] [Related]
9. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
10. Probiotics and antibiotics in IBD.
Sokol H
Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.
Popov J; Caputi V; Nandeesha N; Rodriguez DA; Pai N
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768795
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis.
van de Guchte M; Mondot S; Doré J
Gastroenterology; 2021 Dec; 161(6):1969-1981.e12. PubMed ID: 34508776
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for ulcerative colitis.
Matsuoka K
Immunol Med; 2021 Mar; 44(1):30-34. PubMed ID: 32663072
[TBL] [Abstract][Full Text] [Related]
14. The intestinal microbiota in inflammatory bowel diseases.
Sartor RB
Nestle Nutr Inst Workshop Ser; 2014; 79():29-39. PubMed ID: 25227293
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.
Suskind DL; Singh N; Nielson H; Wahbeh G
J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):27-9. PubMed ID: 25162366
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
17. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
Shanahan F; Quigley EM
Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
[TBL] [Abstract][Full Text] [Related]
19. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.
Magnusson MK; Strid H; Sapnara M; Lasson A; Bajor A; Ung KA; Öhman L
J Crohns Colitis; 2016 Aug; 10(8):943-52. PubMed ID: 26896085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
